Xvivo Perfusion AB (publ) (STO:XVIVO)
Sweden
· Delayed Price · Currency is SEK 269.60
-0.40 (-0.15%)
Apr 29, 2026, 11:49 AM CET
Xvivo Perfusion AB Income Statement
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Revenue | 834.53 | 812.17 | 822.42 | 597.54 | 415.29 | 258.39 | Upgrade
|
| Revenue Growth (YoY) | -2.39% | -1.25% | 37.63% | 43.89% | 60.72% | 43.66% | Upgrade
|
| Cost of Revenue | 224.38 | 212.67 | 206 | 152.43 | 118.34 | 70.11 | Upgrade
|
| Gross Profit | 610.16 | 599.49 | 616.42 | 445.11 | 296.96 | 188.28 | Upgrade
|
| Selling, General & Admin | 382.76 | 376.61 | 378.9 | 309.21 | 223.38 | 153.38 | Upgrade
|
| Research & Development | 131.48 | 130.17 | 147.77 | 135.94 | 69.34 | 54.04 | Upgrade
|
| Other Operating Expenses | -3.88 | -1.7 | -1.09 | -5.43 | -0.22 | -0.39 | Upgrade
|
| Operating Expenses | 510.36 | 505.07 | 525.58 | 439.72 | 292.5 | 207.02 | Upgrade
|
| Operating Income | 99.8 | 94.42 | 90.84 | 5.4 | 4.45 | -18.74 | Upgrade
|
| Interest Expense | - | -3.48 | -1.26 | -1.19 | -0.61 | -0.28 | Upgrade
|
| Interest & Investment Income | 55.9 | 7.88 | 17.16 | 8.85 | 2.12 | - | Upgrade
|
| Currency Exchange Gain (Loss) | -69.96 | -69.96 | 32.39 | 9.69 | 17.09 | 5.98 | Upgrade
|
| Other Non Operating Income (Expenses) | 12.39 | 12.39 | 63.04 | 72.78 | -0.49 | 19.75 | Upgrade
|
| EBT Excluding Unusual Items | 98.12 | 41.25 | 202.16 | 95.52 | 22.58 | 6.71 | Upgrade
|
| Merger & Restructuring Charges | -2.3 | -2.3 | -1.43 | - | - | - | Upgrade
|
| Gain (Loss) on Sale of Assets | -0.39 | -0.39 | -0.78 | -1 | -0.26 | -0.04 | Upgrade
|
| Pretax Income | 95.44 | 38.56 | 199.95 | 94.52 | 22.31 | 6.67 | Upgrade
|
| Income Tax Expense | 21.58 | 13.4 | 27.77 | 2.7 | 3.89 | -1.49 | Upgrade
|
| Net Income | 73.86 | 25.16 | 172.18 | 91.82 | 18.43 | 8.15 | Upgrade
|
| Net Income to Common | 73.86 | 25.16 | 172.18 | 91.82 | 18.43 | 8.15 | Upgrade
|
| Net Income Growth | -46.09% | -85.39% | 87.52% | 398.29% | 126.04% | - | Upgrade
|
| Shares Outstanding (Basic) | 31 | 31 | 31 | 30 | 30 | 29 | Upgrade
|
| Shares Outstanding (Diluted) | 32 | 32 | 32 | 30 | 30 | 29 | Upgrade
|
| Shares Change (YoY) | -0.25% | -0.29% | 5.73% | 1.39% | 2.04% | 6.49% | Upgrade
|
| EPS (Basic) | 2.34 | 0.80 | 5.47 | 3.07 | 0.62 | 0.28 | Upgrade
|
| EPS (Diluted) | 2.34 | 0.80 | 5.44 | 3.07 | 0.62 | 0.28 | Upgrade
|
| EPS Growth | -46.06% | -85.31% | 77.35% | 394.72% | 121.43% | - | Upgrade
|
| Free Cash Flow | 87.97 | 7.35 | 40.56 | 3.27 | 9.67 | -22.25 | Upgrade
|
| Free Cash Flow Per Share | 2.79 | 0.23 | 1.28 | 0.11 | 0.33 | -0.77 | Upgrade
|
| Gross Margin | 73.11% | 73.81% | 74.95% | 74.49% | 71.50% | 72.87% | Upgrade
|
| Operating Margin | 11.96% | 11.63% | 11.04% | 0.90% | 1.07% | -7.25% | Upgrade
|
| Profit Margin | 8.85% | 3.10% | 20.94% | 15.37% | 4.44% | 3.16% | Upgrade
|
| Free Cash Flow Margin | 10.54% | 0.90% | 4.93% | 0.55% | 2.33% | -8.61% | Upgrade
|
| EBITDA | 137.43 | 129.31 | 118.43 | 19.03 | 13.3 | -11.7 | Upgrade
|
| EBITDA Margin | 16.47% | 15.92% | 14.40% | 3.19% | 3.20% | -4.53% | Upgrade
|
| D&A For EBITDA | 37.63 | 34.9 | 27.59 | 13.64 | 8.85 | 7.04 | Upgrade
|
| EBIT | 99.8 | 94.42 | 90.84 | 5.4 | 4.45 | -18.74 | Upgrade
|
| EBIT Margin | 11.96% | 11.63% | 11.04% | 0.90% | 1.07% | -7.25% | Upgrade
|
| Effective Tax Rate | 22.61% | 34.74% | 13.89% | 2.86% | 17.42% | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.